Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
60
MEDP Quote, Financials, Valuation and Earnings
Last price:
$571.39
Seasonality move
:
-3.36%
Day range:
$560.77 - $574.25
52-week range:
$250.05 - $626.26
Dividend yield:
0%
P/E ratio:
39.97x
P/S ratio:
7.33x
P/B ratio:
54.83x
Volume:
207.4K
Avg. volume:
265K
1-year change:
69.45%
Market cap:
$16.1B
Revenue:
$2.1B
EPS (TTM):
$14.30
Analysts' Opinion
-
Consensus RatingMedpace Holdings, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 8 Hold ratings, and 3 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $541.92, Medpace Holdings, Inc. has an estimated downside of -5.18% from its current price of $571.53.
-
Price Target UpsideAccording to analysts, the highest upside price target is $655.00 representing -100% upside increase from its current price of $571.53.
Fair Value
-
According to the consensus of 12 analysts, Medpace Holdings, Inc. has -5.18% downside to fair value with a price target of $541.92 per share.
MEDP vs. S&P 500
-
Over the past 5 trading days, Medpace Holdings, Inc. has underperformed the S&P 500 by -0.12% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Medpace Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medpace Holdings, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Medpace Holdings, Inc. reported revenues of $659.9M.
Earnings Growth
-
Medpace Holdings, Inc. has grown year-over-year earnings for 15 quarters straight. In the most recent quarter Medpace Holdings, Inc. reported earnings per share of $3.86.
Enterprise value:
16B
EV / Invested capital:
36.47x
Price / LTM sales:
7.33x
EV / EBIT:
31.47x
EV / Revenue:
6.77x
PEG ratio (5yr expected):
1.59x
EV / Free cash flow:
23.58x
Price / Operating cash flow:
25.55x
Enterprise value / EBITDA:
29.80x
Gross Profit (TTM):
$705.1M
Return On Assets:
23.02%
Net Income Margin (TTM):
18.36%
Return On Equity:
78.26%
Return On Invested Capital:
61.64%
Operating Margin:
21.49%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.8B | $2.1B | $2.4B | $533.3M | $659.9M | |
| Gross Profit | $478.2M | $586.1M | $705.1M | $161.5M | $189.9M | |
| Operating Income | $325.9M | $408.8M | $507M | $112.3M | $141.8M | |
| EBITDA | $365.4M | $437.5M | $535.5M | $119.8M | $148.9M | |
| Diluted EPS | $8.53 | $11.42 | $14.30 | $3.01 | $3.86 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $641.2M | $337.7M | $448.9M | $1B | $737.3M | |
| Total Assets | $1.6B | $1.3B | $1.5B | $2.1B | $1.8B | |
| Current Liabilities | $517.2M | $820.9M | $848.5M | $1B | $1.3B | |
| Total Liabilities | $679.1M | $978.5M | $1B | $1.2B | $1.5B | |
| Total Equity | $898.1M | $349.9M | $470.9M | $881.4M | $293.6M | |
| Total Debt | $128.2M | $139.2M | $143M | $128.3M | $119.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $413.7M | $574.5M | $711.2M | $149.1M | $246.2M | |
| Cash From Investing | -$35.9M | -$28.7M | -$34.2M | -$10.5M | -$10.7M | |
| Cash From Financing | -$315.3M | $16.1M | -$1.1B | $6.3M | $3.4M | |
| Free Cash Flow | $377.8M | $535.7M | $676.8M | $138.5M | $235.5M | |
MEDP
Sector
Market Cap
$16.1B
$27.9M
Price % of 52-Week High
91.26%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
7.28%
-1.49%
1-Year Price Total Return
69.45%
-16.66%
Beta (5-Year)
1.427
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$562.39
200-day SMA
Buy
Level
$423.17
Bollinger Bands (100)
Buy
Level
474.44 - 581.7
Chaikin Money Flow
Buy
Level
31.1M
20-day SMA
Buy
Level
$571.18
Relative Strength Index (RSI14)
Buy
Level
51.64
ADX Line
Sell
Level
18.16
Williams %R
Neutral
Level
-33.6983
50-day SMA
Sell
Level
$573.88
MACD (12, 26)
Sell
Level
-3.96
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
46.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.456)
Buy
CA Score
(Annual)
Level (0.4441)
Buy
Beneish M-Score
(Annual)
Level (-3.0534)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.2533)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Stock Forecast FAQ
In the current month, MEDP has received 1 Buy ratings 8 Hold ratings, and 3 Sell ratings. The MEDP average analyst price target in the past 3 months is $541.92.
-
Where Will Medpace Holdings, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medpace Holdings, Inc. share price will drop to $541.92 per share over the next 12 months.
-
What Do Analysts Say About Medpace Holdings, Inc.?
Analysts are divided on their view about Medpace Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Medpace Holdings, Inc. is a Buy and believe this share price will rise from its current level to $655.00.
-
What Is Medpace Holdings, Inc.'s Price Target?
The price target for Medpace Holdings, Inc. over the next 1-year time period is forecast to be $541.92 according to 12 Wall Street analysts, 1 of them rates the stock a Buy, 3 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is MEDP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medpace Holdings, Inc. is a Hold. 8 of 12 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MEDP?
You can purchase shares of Medpace Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medpace Holdings, Inc. shares.
-
What Is The Medpace Holdings, Inc. Share Price Today?
Medpace Holdings, Inc. was last trading at $571.39 per share. This represents the most recent stock quote for Medpace Holdings, Inc.. Yesterday, Medpace Holdings, Inc. closed at $571.53 per share.
-
How To Buy Medpace Holdings, Inc. Stock Online?
In order to purchase Medpace Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MEDP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MEDP
Sector
P/E ratio
39.97x
23.85x
PEG ratio
1.59x
-0.01x
P/B ratio
54.83x
1.81x
Price / LTM sales
7.33x
1.58x
Growth Metrics
MEDP
Sector
Revenue growth
23.74%
4.62%
Earnings growth
28.34%
10.7%
Revenue (5-year growth)
19.63%
6.5%
Earnings forecast
$3.57
-$0.21
Profitability
MEDP
Sector
Profitability FY 2024
$627.1M
$3.6M
Return on invested capital
61.64%
-31.87%
Return on assets
23.02%
-28.18%
Return on equity
78.26%
-37.63%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Feb
9
Estimated Next Earnings Date
Jan
21
Balance Sheet
MEDP
Sector
Total cash
$285.4M
$26.4M
Short term investments
--
$25.7M
Total assets
$2.1B
$76.9M
Long term debt
$119.1M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 24.71% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is up 20.67% over the past day.
Buy
84
RKLB alert for Dec 23
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
